| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Allergic bronchopulmonary aspergillosis with chest pain as atypical symptoms
|
Chen, Ting Ting
|
|
|
22 |
1 |
p. 150
|
artikel
|
| 2 |
A new treatment for drug-resistant tuberculosis in Ukraine
|
Holt, Ed
|
|
|
22 |
1 |
p. 23
|
artikel
|
| 3 |
Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
|
Romero, Carolina
|
|
|
22 |
1 |
p. 19
|
artikel
|
| 4 |
Arjen Dondorp—eliminating malaria in southeast Asia
|
Kirby, Tony
|
|
|
22 |
1 |
p. 32
|
artikel
|
| 5 |
Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study
|
Wan, Eric Yuk Fai
|
|
|
22 |
1 |
p. 64-72
|
artikel
|
| 6 |
Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial
|
Shinde, Vivek
|
|
|
22 |
1 |
p. 73-84
|
artikel
|
| 7 |
Comparison of three tests for latent tuberculosis infection in high-risk people in the USA: an observational cohort study
|
Ho, Christine S
|
|
|
22 |
1 |
p. 85-96
|
artikel
|
| 8 |
Correction to Lancet Infect Dis 2021; 21: 1485–86
|
|
|
|
22 |
1 |
p. e1
|
artikel
|
| 9 |
Correction to Lancet Infect Dis 2021; 21: 1097–106
|
|
|
|
22 |
1 |
p. e1
|
artikel
|
| 10 |
Correction to Lancet Infect Dis 2022; 22: 136–49
|
|
|
|
22 |
1 |
p. e1
|
artikel
|
| 11 |
Correction to Lancet Infect Dis 2021; 21: 1491–92
|
|
|
|
22 |
1 |
p. e1
|
artikel
|
| 12 |
COVID-19 vaccine mandates in Europe
|
Burki, Talha
|
|
|
22 |
1 |
p. 27-28
|
artikel
|
| 13 |
Do health-care workers need a COVID-19 vaccine booster?
|
Cirillo, Nicola
|
|
|
22 |
1 |
p. 20
|
artikel
|
| 14 |
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study
|
Sauré, Denis
|
|
|
22 |
1 |
p. 56-63
|
artikel
|
| 15 |
Ebola vaccines for mass immunisation in affected regions
|
Agnandji, Selidji Todagbe
|
|
|
22 |
1 |
p. 8-10
|
artikel
|
| 16 |
Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study
|
Kokaliaris, Christos
|
|
|
22 |
1 |
p. 136-149
|
artikel
|
| 17 |
Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial
|
Hürlimann, Eveline
|
|
|
22 |
1 |
p. 123-135
|
artikel
|
| 18 |
Emerging SARS-CoV-2 variants: shooting the messenger
|
The Lancet Infectious Diseases,
|
|
|
22 |
1 |
p. 1
|
artikel
|
| 19 |
Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study
|
Twohig, Katherine A
|
|
|
22 |
1 |
p. 35-42
|
artikel
|
| 20 |
How to be prepared for the future
|
MacIntyre, Raina
|
|
|
22 |
1 |
p. 34
|
artikel
|
| 21 |
Importance of epidemiological factors in the evaluation of transmissibility and clinical severity of SARS-CoV-2 variants
|
Lechien, Jérôme R
|
|
|
22 |
1 |
p. 2-3
|
artikel
|
| 22 |
Infectious disease surveillance update
|
Islam, Tanzina
|
|
|
22 |
1 |
p. 28
|
artikel
|
| 23 |
Is violence the only option to obtain health for HIV prisoners?
|
Dawson, Quintina
|
|
|
22 |
1 |
p. 33
|
artikel
|
| 24 |
Ivermectin and albendazole against Trichuris trichiura: a long and winding road
|
Barda, Beatrice
|
|
|
22 |
1 |
p. 10-12
|
artikel
|
| 25 |
Jeanne Rini Poespoprodjo—fighting malaria in Papua
|
Kenyon, Georgina
|
|
|
22 |
1 |
p. 31
|
artikel
|
| 26 |
Long-acting injectable for HIV approved for use in the UK
|
Kirby, Tony
|
|
|
22 |
1 |
p. 26
|
artikel
|
| 27 |
Martha Lepow
|
Bagcchi, Sanjeet
|
|
|
22 |
1 |
p. 30
|
artikel
|
| 28 |
Medical countermeasures against henipaviruses: a review and public health perspective
|
Gómez Román, Raúl
|
|
|
22 |
1 |
p. e13-e27
|
artikel
|
| 29 |
Our new cover artist for 2022
|
De Ambrogi, Marco
|
|
|
22 |
1 |
p. 2
|
artikel
|
| 30 |
Pertussis vaccination in Chinese children with increasing reported pertussis cases
|
Zhang, Jiaosheng
|
|
|
22 |
1 |
p. 21-22
|
artikel
|
| 31 |
Practical measures for SARS-CoV-2 infection prevention
|
Fujikawa, Tatsuya
|
|
|
22 |
1 |
p. 20-21
|
artikel
|
| 32 |
Practical measures for SARS-CoV-2 infection prevention – Authors' reply
|
Llibre, Josep M
|
|
|
22 |
1 |
p. 21
|
artikel
|
| 33 |
Protection against COVID-19: beyond antibodies
|
Lacerda, Marcus Vinícius Guimarães
|
|
|
22 |
1 |
p. 4-5
|
artikel
|
| 34 |
Protective immunity after recovery from SARS-CoV-2 infection
|
Kojima, Noah
|
|
|
22 |
1 |
p. 12-14
|
artikel
|
| 35 |
Quadrivalent adjuvanted haemagglutinin nanoparticle influenza vaccine: a step towards better protection of older adults from the constantly mutating H3N2 influenza viruses
|
Isakova-Sivak, Irina
|
|
|
22 |
1 |
p. 7-8
|
artikel
|
| 36 |
Research in brief
|
Devi, Sharmila
|
|
|
22 |
1 |
p. 29
|
artikel
|
| 37 |
Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study
|
Antonelli, Michela
|
|
|
22 |
1 |
p. 43-55
|
artikel
|
| 38 |
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in children in Sierra Leone: a randomised, double-blind, controlled trial
|
Afolabi, Muhammed O
|
|
|
22 |
1 |
p. 110-122
|
artikel
|
| 39 |
Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
|
Ishola, David
|
|
|
22 |
1 |
p. 97-109
|
artikel
|
| 40 |
Serial antigen rapid testing in staff of a large acute hospital
|
Wu, Sean
|
|
|
22 |
1 |
p. 14-15
|
artikel
|
| 41 |
The association between COVID-19 vaccination and Bell's palsy
|
Cirillo, Nicola
|
|
|
22 |
1 |
p. 5-6
|
artikel
|
| 42 |
The importance of enterovirus surveillance in a post-polio world
|
Fischer, Thea K
|
|
|
22 |
1 |
p. e35-e40
|
artikel
|
| 43 |
The urgent need for metallo-β-lactamase inhibitors: an unattended global threat
|
Mojica, Maria F
|
|
|
22 |
1 |
p. e28-e34
|
artikel
|
| 44 |
Transmissibility of SARS-CoV-2 among fully vaccinated individuals
|
Franco-Paredes, Carlos
|
|
|
22 |
1 |
p. 16
|
artikel
|
| 45 |
Transmissibility of SARS-CoV-2 among fully vaccinated individuals
|
Knol, Mirjam J
|
|
|
22 |
1 |
p. 16-17
|
artikel
|
| 46 |
Transmissibility of SARS-CoV-2 among fully vaccinated individuals
|
Ko, Humphrey H T
|
|
|
22 |
1 |
p. 17-18
|
artikel
|
| 47 |
Transmissibility of SARS-CoV-2 among fully vaccinated individuals – Authors' reply
|
Lalvani, Ajit
|
|
|
22 |
1 |
p. 18-19
|
artikel
|
| 48 |
Updates in sepsis management
|
Mushtaq, Ammara
|
|
|
22 |
1 |
p. 24
|
artikel
|
| 49 |
What is the role of science academies in Africa?
|
Nakkazi, Esther
|
|
|
22 |
1 |
p. 25
|
artikel
|
| 50 |
100 years of Mycobacterium bovis bacille Calmette-Guérin
|
Lange, Christoph
|
|
|
22 |
1 |
p. e2-e12
|
artikel
|
Tijdschrift beschrijving